Opportunity Information: Apply for PAR 18 543
Apply for PAR 18 543
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "CREATE Bio Development Track: Preclinical and Early-Phase Clinical Development for Biologics (U44 SBIR- Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.853.
- This funding opportunity was created on 2017-12-20.
- Applicants must submit their applications by 2021-05-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2024.)
- Eligible applicants include: Small businesses.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Basic and Translational Research on Decision Making in Aging and Alzheimer's Disease (R01 - Clinical Trial Optional)
Previous opportunity: Assessment of Natural Resource Conditions for First State National Historical Park
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 18 543
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 18 543) also looked into and applied for these:
| Funding Opportunity |
|---|
| Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01) Apply for PAR 18 534 Funding Number: PAR 18 534 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Human Cell Biology of Alzheimer's Disease Genetic Variants (R01 - Clinical Trial Not Allowed) Apply for PAR 18 516 Funding Number: PAR 18 516 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NEI Collaborative Clinical Vision Research Project: Coordinating Center Grant (UG1 Clinical Trial Required) Apply for PAR 18 521 Funding Number: PAR 18 521 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Radiological/Nuclear Medical Countermeasure Product Development Program (SBIR) (R43/R44 Clinical Trial Not Allowed) Apply for PA 18 525 Funding Number: PA 18 525 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NEI Collaborative Clinical Vision Research : Chair's Grant (UG1-Clinical Trial Required) Apply for PAR 18 523 Funding Number: PAR 18 523 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Sensory and motor system changes as predictors of preclinical Alzheimers disease (R01 - Clinical Trial Not Allowed) Apply for PAR 18 519 Funding Number: PAR 18 519 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS CREATE Bio Development Track: Preclinical Development for Biotechnology Products and Biologics (U01 - Clinical Trial Optional) Apply for PAR 18 542 Funding Number: PAR 18 542 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| NeuroNEXT Clinical Trials (U01 - Clinical Trial Optional) Apply for PAR 18 528 Funding Number: PAR 18 528 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01- Clinical Trials Optional) Apply for PAR 18 533 Funding Number: PAR 18 533 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Understanding the Effects of ApoE2 on the Interaction between Aging and Alzheimers Disease (R01 - Clinical Trial Not Allowed) Apply for RFA AG 18 022 Funding Number: RFA AG 18 022 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Institutional Training Programs to Advance Translational Research on Alzheimer's Disease and AD Related Dementias (T32 - Clinical Trial Not Allowed) Apply for PAR 18 524 Funding Number: PAR 18 524 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3) - Clinical Trial Required Apply for PAR 18 547 Funding Number: PAR 18 547 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Basic and Translation Research on Decision Making in Aging and Alzheimer's Disease (R21 - Clinical Trial Optional) Apply for PAR 18 538 Funding Number: PAR 18 538 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Basic and Translational Research on Decision Making in Aging and Alzheimer's Disease (R01 - Clinical Trial Optional) Apply for PAR 18 544 Funding Number: PAR 18 544 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clinical Validation of a Candidate Biomarker for Neurological Disease (U44 - Clinical Trial Optional) Apply for PAR 18 548 Funding Number: PAR 18 548 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Analytical Validation of a Candidate Biomarker for Neurological Disease (U44 - Clinical Trial Optional) Apply for PAR 18 549 Funding Number: PAR 18 549 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Analytical Validation of Candidate Biomarkers for Neurological Disease (U01 Clinical Trial Optional) Apply for PAR 18 550 Funding Number: PAR 18 550 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R21 Clinical Trial Optional) Apply for PAR 18 554 Funding Number: PAR 18 554 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| NIDCD Clinical Research Center Grant (P50 - Clinical Trials Optional) Apply for PAR 18 556 Funding Number: PAR 18 556 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research on Comparative Effectiveness and Implementation of HIV/AIDS and Alcohol Interventions (R01 - Clinical Trials Optional) Apply for PAS 18 557 Funding Number: PAS 18 557 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 18 543", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.